RESISTANT CANCER

Clinical trials for RESISTANT CANCER explained in plain language.

Never miss a new study

Get alerted when new RESISTANT CANCER trials appear

Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New combo tackles Drug-Resistant liver cancer in small trial

Disease control Terminated

This study tested a combination of two drugs (lenvatinib and VIC-1911) in 5 adults with advanced liver cancer that no longer responded to lenvatinib alone. The goal was to see if the combo was safe and could slow cancer growth. The trial was terminated early, so results are limit…

Matched conditions: RESISTANT CANCER

Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control

Last updated May 08, 2026 12:04 UTC

RESISTANT CANCER

Get alerted when new RESISTANT CANCER trials appear

New combo tackles Drug-Resistant liver cancer in small trial